Tretinoin transdermal - Stiefel Laboratories
Alternative Names: Tretinoin LiquipatchLatest Information Update: 02 Oct 2021
At a glance
- Originator Stiefel Laboratories
- Class Antiacnes; Antineoplastics; Cyclohexenes; Keratolytics; Retinoids; Small molecules
- Mechanism of Action Protein synthesis inhibitors; Retinoic acid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Acne
Most Recent Events
- 22 Jul 2009 Stiefel Laboratories has been acquired by GlaxoSmithKline
- 28 Dec 2006 Connetics Corporation has been acquired and merged into Stiefel Laboratories
- 09 Apr 2003 Preclinical data presented at the 61st Annual Meeting of the American Academy of Dermatology (AAD-2003) has been added to the Antibacterial pharmacodynamics section